DermTech
In Brief This Week: Bristol Myers Squibb, Kinnate Biopharma, Biocept, Nexcella, DermTech
News items for the week of Sept. 18, 2023.
DermTech to Cut 15 Percent of Workforce in Restructuring to Focus on Skin Cancer Test
The San Diego-based company said it will halt its pipeline programs in order to focus on growing volume and reimbursement for its noninvasive melanoma DNA test.
In Brief This Week: Pillar Biosciences, BioMark Diagnostics, DermTech, Perspective Therapeutics
News items for the week of Feb. 6, 2023.